b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2263130/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for \xe2\x80\x9cHoles\xe2\x80\x9d in the T Cell Repertoire</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2263130/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for \xe2\x80\x9cHoles\xe2\x80\x9d in the T Cell Repertoire" /><meta name="citation_authors" content="Sune Frankild, Rob J. de Boer, Ole Lund, Morten Nielsen, Can Kesmir" /><meta name="citation_date" content="2008" /><meta name="citation_issue" content="3" /><meta name="citation_volume" content="3" /><meta name="citation_doi" content="10.1371/journal.pone.0001831" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2263130/?report=abstract" /><meta name="citation_pmid" content="18350167" /><meta name="DC.Title" content="Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for \xe2\x80\x9cHoles\xe2\x80\x9d in the T Cell Repertoire" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Sune Frankild" /><meta name="DC.Contributor" content="Rob J. de Boer" /><meta name="DC.Contributor" content="Ole Lund" /><meta name="DC.Contributor" content="Morten Nielsen" /><meta name="DC.Contributor" content="Can Kesmir" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1371/journal.pone.0001831" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for \xe2\x80\x9cHoles\xe2\x80\x9d in the T Cell Repertoire" /><meta property="og:type" content="article" /><meta property="og:description" content="Cytotoxic T cell (CTL) cross-reactivity is believed to play a pivotal role in generating immune responses but the extent and mechanisms of CTL cross-reactivity remain largely unknown. Several studies suggest that CTL clones can recognize highly diverse ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2263130/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2263130/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2263130/pdf/pone.0001831.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A47C9E99B04610000000000BE00BE.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/161333/">v.3(3); 2008</a></li><li class="accid">PMC2263130</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0001831" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2008; 3(3): e1831. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Mar 19. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0001831" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0001831</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2263130</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18350167">18350167</a></div></div></div></div><h1 class="content-title">Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for &#x0201c;Holes&#x0201d; in the T Cell Repertoire</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Frankild%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167" class="affpopup" co-rid="_co_idm139830859826480" co-class="co-affbox">Sune Frankild</a>,<sup>\n1\n</sup> <a href="/pubmed/?term=de%20Boer%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167" class="affpopup" co-rid="_co_idm139830894451712" co-class="co-affbox">Rob J. de Boer</a>,<sup>\n2\n</sup> <a href="/pubmed/?term=Lund%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167" class="affpopup" co-rid="_co_idm139830894449680" co-class="co-affbox">Ole Lund</a>,<sup>\n1\n</sup> <a href="/pubmed/?term=Nielsen%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167" class="affpopup" co-rid="_co_idm139830894447312" co-class="co-affbox">Morten Nielsen</a>,<sup>\n1\n,</sup><sup>\n&#x0002a;\n</sup> and  <a href="/pubmed/?term=Kesmir%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167" class="affpopup" co-rid="_co_idm139830854960512" co-class="co-affbox">Can Kesmir</a><sup>\n2\n,</sup><sup>\n3\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139830859826480"><h3 class="no_margin">Sune Frankild</h3><p>  <sup>1</sup>  Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark,   </p><div>Find articles by <a href="/pubmed/?term=Frankild%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167">Sune Frankild</a></div></div><div id="_co_idm139830894451712"><h3 class="no_margin">Rob J. de Boer</h3><p>  <sup>2</sup>  Theoretical Biology/Bioinformatics, University of Utrecht, Utrecht, The Netherlands,   </p><div>Find articles by <a href="/pubmed/?term=de%20Boer%20RJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167">Rob J. de Boer</a></div></div><div id="_co_idm139830894449680"><h3 class="no_margin">Ole Lund</h3><p>  <sup>1</sup>  Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark,   </p><div>Find articles by <a href="/pubmed/?term=Lund%20O%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167">Ole Lund</a></div></div><div id="_co_idm139830894447312"><h3 class="no_margin">Morten Nielsen</h3><p>  <sup>1</sup>  Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark,   </p><div>Find articles by <a href="/pubmed/?term=Nielsen%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167">Morten Nielsen</a></div></div><div id="_co_idm139830854960512"><h3 class="no_margin">Can Kesmir</h3><p>  <sup>2</sup>  Theoretical Biology/Bioinformatics, University of Utrecht, Utrecht, The Netherlands,   </p><p>  <sup>3</sup>  Academic Biomedical Centre, University of Utrecht, Utrecht, The Netherlands,   </p><div>Find articles by <a href="/pubmed/?term=Kesmir%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18350167">Can Kesmir</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Linqi Zhang, <span class="fm-role">Academic Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139830856167616_ai idm139830859826608_ai idm139830891418688_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139830856167616_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139830856167616_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139830856167616_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Theoretical Biology/Bioinformatics, University of Utrecht, Utrecht, The Netherlands,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  Academic Biomedical Centre, University of Utrecht, Utrecht, The Netherlands,   </div><div class="fm-affl" lang="en" id="edit1">AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College, China</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="kd.utd.sbc@leinm" class="oemail">kd.utd.sbc@leinm</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: OL MN SF CK. Performed the experiments: MN SF CK. Analyzed the data: MN SF CK. Contributed reagents/materials/analysis tools: SF. Wrote the paper: OL MN SF CK RJ.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139830856167616_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Dec 21; Accepted 2008 Feb 18.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139830856167616_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2263130/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139830932256272" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139830932256272title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">Cytotoxic T cell (CTL) cross-reactivity is believed to play a pivotal role in generating immune responses but the extent and mechanisms of CTL cross-reactivity remain largely unknown. Several studies suggest that CTL clones can recognize highly diverse peptides, some sharing no obvious sequence identity. The emerging realization in the field is that T cell receptors (TcR) recognize multiple <strong>distinct</strong> ligands.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Principal Findings</h3><p id="__p3" class="p p-first-last">First, we analyzed peptide scans of the HIV epitope SLFNTVATL (SFL9) and found that TCR specificity is position dependent and that biochemically similar amino acid substitutions do not drastically affect recognition. Inspired by this, we developed a general model of TCR peptide recognition using amino acid similarity matrices and found that such a model was able to predict the cross-reactivity of a diverse set of CTL epitopes. With this model, we were able to demonstrate that seemingly distinct T cell epitopes, i.e., ones with low sequence identity, are in fact more biochemically similar than expected. Additionally, an analysis of HIV immunogenicity data with our model showed that CTLs have the tendency to respond mostly to peptides that do not resemble self-antigens.</p></div><div id="__sec3" class="sec sec-last"><h3 id="__sec3title">Conclusions</h3><p id="__p4" class="p p-first-last">T cell cross-reactivity can thus, to an extent greater than earlier appreciated, be explained by amino acid similarity. The results presented in this paper will help resolving some of the long-lasting discussions in the field of T cell cross-reactivity.</p></div></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p5" class="p p-first-last">Each T cell expresses thousands of T cell receptors (TCR) of a single specificity that allows inspection of peptide fragments bound by major histocompatibility complex molecules (MHC) on the surface of other cells. Peptides originate as the product of intracellular protein turnover, and both foreign and self-peptides are able to form peptide:MHC complexes (pMHC). Presentation of peptides for which the inspecting CTLs have not been tolerized, triggers a cytotoxic response. Although much has been learned about peptide processing and MHC presentation <a href="#pone.0001831-Moutaftsi1" rid="pone.0001831-Moutaftsi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698925">[1]</a>, <a href="#pone.0001831-Peters1" rid="pone.0001831-Peters1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698922">[2]</a> it is still largely unknown why roughly half of all natural foreign pMHC are ignored <a href="#pone.0001831-Yewdell1" rid="pone.0001831-Yewdell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698919">[3]</a>, <a href="#pone.0001831-Assarsson1" rid="pone.0001831-Assarsson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698933">[4]</a>. The processing and MHC binding of naturally processed foreign peptides is a primary requirement for the initiation of a cellular immune response. However, the availability of a suitable TCR further determines if a peptide is immunogenic. The structural mechanism of T cell recognition is a highly debated subject in the immunological literature and a consensus view of the promiscuous peptide recognition has not yet been reached (see e.g., <a href="#pone.0001831-Rudolph1" rid="pone.0001831-Rudolph1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698934">[5]</a>). The core problem is that T cells seem to combine high specificity with the ability to recognize a surprisingly large number of dissimilar antigens. Two terms are often used to describe this nature of T cell recognition. <strong>Poly-specificity</strong> is used to emphasize TCR\'s ability to recognize multiple distinct/unrelated pMHC ligands with high specificity (with little or no tolerance to substitutions of the ligands) <a href="#pone.0001831-Wucherpfennig1" rid="pone.0001831-Wucherpfennig1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698902">[6]</a>, <a href="#pone.0001831-Felix1" rid="pone.0001831-Felix1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698901">[7]</a>. <strong>Cross-reactivity</strong> is a term that was originally used to indicate unexpected reactivity to targets that differed from those used to initially define the T cell clone <a href="#pone.0001831-Mason1" rid="pone.0001831-Mason1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698928">[8]</a>. Several studies suggest that T cells can recognize seemingly dissimilar epitopes (for a summary see <a href="#pone.0001831-Wucherpfennig1" rid="pone.0001831-Wucherpfennig1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698921">[6]</a>), while other studies have established that substitutions affect peptide recognition in a predictable and additive manner <a href="#pone.0001831-Hemmer1" rid="pone.0001831-Hemmer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698935">[9]</a> suggesting that the majority of cross-reactive pMHC complexes share structural similarities. One outstanding question in T cell biology is therefore whether T cell cross-reactivity is mostly a stochastic phenomenon induced by unpredictable structural constraints or, whether we can predict which peptides should be cross-reactive. Previous studies of cross-reactivity have focused on limited data covering a single or a few T cell clones. Here, we investigate a simple model of T cell cross-reactivity and perform a large-scale analysis spanning both a broad set of experimental settings, heterogeneous pathogens, MHC molecules and T cell clones. We use this benchmark to investigate whether cross-reactivity is either generally predictable or mostly random. Finally, we test whether the degree of host mimicry is negatively correlated with immunogenicity. By analyzing a large set of known HLA-A2 restricted HIV epitopes, we investigate if potential HIV epitopes with high similarity to self are able to trigger detectable immune responses. Our results suggest that amino acid similarity, rather than identity, is a predictive measure of cross-reactivity.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Results</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Visualizing TCR recognition sensitivity toward single mutations</h3><p id="__p6" class="p p-first">We analyzed public data on CTL sensitivity and created a visualization of how CTLs react to single amino acid substitutions. Lee et al. <a href="#pone.0001831-Lee1" rid="pone.0001831-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698908">[10]</a> analyzed the specificity of CTL responses against the immunodominant HLA-A2 restricted HIV Gag epitope SLFNTVATL (SFL9). IFN&#x003b3; production was measured in response against all 171 single mutant variants of SFL9. Abrogated TCR responses were mostly due to loss of TCR binding as the majority of SFL9 variants retained binding to MHC. The cross reactivity data for the three data sets: G10, T4 and PBMC were converted into a position-specific-scoring-matrix (PSSM) as described in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>. The recognition motif of the T4 clone (the PSSM matrix) is visualized in <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1A</span></a> as a Logo plot <a href="#pone.0001831-Schneider1" rid="pone.0001831-Schneider1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698916">[11]</a>. The plot shows a stack of the possible amino acid mutations on each position in SLFNTVATL (x-axis). The height of the stack is reciprocal to the number of tolerated mutations (i.e., it indicates the degree of T cell recognition specificity at this position, see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>). Few tolerated mutations translate into tall stacks while many tolerated mutations show up as short stacks (bars). For example, in position five, only one variant is tolerated (T5S) and is shown as a tall bar. The remaining variants on position 5 were unable to bind the TCR even though the binding to MHC was mostly preserved. On the contrary, in position one, 18 out of 19 variants preserved the TCR recognition. The logo plot for CTL clone T4 given in <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1A</span></a> suggests that the central peptide positions are most important for peptide-TCR binding, which is in agreement with earlier data <a href="#pone.0001831-Garcia1" rid="pone.0001831-Garcia1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698893">[12]</a>, <a href="#pone.0001831-Arden1" rid="pone.0001831-Arden1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698924">[13]</a>. The average Shannon information <a href="#pone.0001831-Shannon1" rid="pone.0001831-Shannon1" class=" bibr popnode">[14]</a> plot for T4, G10 clones and PBMC is shown in <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1C</span></a>. This figure also indicates that positions 2&#x02013;6 and 8&#x02013;9 are most important for peptide recognition whereas position one is consistently of little importance. Position 2 and 9 are the main positions determining peptide binding to the HLA-A&#x0002a;0201 molecule, see <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1B</span></a>. Thus, positions 3&#x02013;6 and 8 were consistently involved in the primary TCR recognition motif. Moreover, the sequence motif for T4 clone suggests that tolerated substitutions tend to be conservative with respect to the original epitope sequence, SLFNTVATL. Examples are F3Y (both non-polar and aromatic), T5S (both polar), and V6I (both aliphatic). Similar observations on tolerated substitutions were made for the other two CTL clones (data not shown). Taken together, these data suggest that amino acid similarity could be a major component of T cell recognition.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139830891206368" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2263130_pone.0001831.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001831.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2263130/bin/pone.0001831.g001.jpg" /></a></div><div id="largeobj_idm139830891206368" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001831-g001"><div><a class="figpopup" href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>TCR and MHC binding motifs.</strong><p id="__p7">(A) Logo plot <a href="#pone.0001831-Schneider1" rid="pone.0001831-Schneider1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698937">[11]</a> of recognized single variant peptides for CTL clone T4. The x-axis shows the positions in SLFNTVATL. The letters stacked on top of each position are the accepted amino acid substitutions. The y-axis gives Shannon information <a href="#pone.0001831-Shannon1" rid="pone.0001831-Shannon1" class=" bibr popnode">[14]</a> which is a measure of how conserved a position is. Rigid positions have few but tall letters, while very degenerate positions have many but very short letters. For example, position 1 was mutated 19 times of which 18 variants preserved TCR binding, only the S1R variant compromised TCR binding while the MHC binding was preserved (see <a href="#pone.0001831-Lund1" rid="pone.0001831-Lund1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698932">[38]</a>). The frequency of amino acids occurring in this TCR motif can also be used to estimate the number of distinct ligands this T cell clone can recognize (see text for details). (B) Sequence motif of HLA-A2 binding peptides (277 HLA-A2 restricted peptides were extracted from the SYFPEITHI database <a href="#pone.0001831-Rammensee1" rid="pone.0001831-Rammensee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698915">[15]</a>). (C) The average Shannon information at each position, for the CTL clones: G10 and T4, and PBMC.</p></div></div></div></div><div id="s2b" class="sec"><h3 id="s2btitle">How many different ligands can a TCR recognize?</h3><p id="__p8" class="p p-first-last">Using the information in the TCR amino acid position specific scoring matrices, we estimate the number of ligands recognized by a given T cell clone by assuming that recognizable peptides contain only those amino acids giving a detectable ELISPOT response in the Lee et al. <a href="#pone.0001831-Lee1" rid="pone.0001831-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698936">[10]</a> study. Non-recognized peptides are the ones containing at least one prohibited amino acid for which no response was detected. The number of recognizable peptides was computed by the following procedure. The degeneracy of a TCR on a single position was measured as the diversity of amino acids present at that position defined in terms of the Simpson index (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>). This diversity measure yields a value between 1 and 20. Here, 20 means that all amino acids are used with equal frequency at a position, and 1 means that only a single amino acid is found. The higher the diversity the more degenerate the TCR is at this position. In the binding motif of T4 clone (<a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1A</span></a>) the first position diversity is very high, 13.26, as expected, because this position is highly degenerate. In the conserved position five, the Simpson diversity drops to 1.29. The product of the tolerated amino acid diversity at each position can provide an estimate of the number of ligands a T cell clone can recognize. For T4, we estimate a total of 5.6&#x022c5;10<sup>5</sup> ligands in this way and this value is in good agreement with previous estimates <a href="#pone.0001831-Mason1" rid="pone.0001831-Mason1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698923">[8]</a>. For the G10 clone, we estimate 3.2&#x022c5;10<sup>6</sup> ligands, suggesting that this clone is more degenerate. Similarly, one can estimate the number of ligands that can bind to a MHC molecule. For example, the HLA-A&#x0002a;0201 molecule (see <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1B</span></a> for the binding motif) can bind 4.8&#x022c5;10<sup>9</sup> distinct peptides <a href="#pone.0001831-Rammensee1" rid="pone.0001831-Rammensee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698931">[15]</a>. Thus, measured in this way the CTL binding event is three orders of magnitudes more specific than that of the MHC.</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">CTL cross-reactivity modeled by peptide similarity</h3><p id="__p9" class="p p-first-last">The above calculation suggests that a single T cell receptor can recognize as many as 10<sup>6</sup> ligands. How related are these ligands, and is the cross-reactivity of a T cell clone predictable? A few studies suggest that cross-reactivity is not completely random <a href="#pone.0001831-Hemmer1" rid="pone.0001831-Hemmer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698917">[9]</a>, <a href="#pone.0001831-Tangri1" rid="pone.0001831-Tangri1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698887">[16]</a>, while others argue that T cells can recognize unrelated ligands (see e.g. <a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698913">[17]</a>). Here, we investigate whether TCR peptide cross-recognition can be predicted by a quantitative model of peptide similarity using amino acid similarity matrices (SM) as explained in detail in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>. The peptide similarity score is unity for two identical peptides, and 0 for peptides of maximum dissimilarity, as defined by the SM. Note, that this simple model does not differentiate between positions. Below, the predictions made from this model are tested on several independent data sets, and compared against the performance of random predictors.</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">Predicted cross-reactivity of SLFNTVATL variants</h3><p id="__p10" class="p p-first">\n<a href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002" co-legend-rid="lgnd_pone-0001831-g002"><span>Fig. 2</span></a> shows box plots of the level of IFN&#x003b3; response of three CTL clones in response to stimulation with the 171 variant peptides of SLFNTVATL (data from Lee et al. <a href="#pone.0001831-Lee1" rid="pone.0001831-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698886">[10]</a>). The Pearson correlation coefficients between their relative SFU and our peptide similarity score were: 0.40, 0.39, and 0.35 for G10, T4, and PBMC data, respectively (p&#x0003c;0.0001, Monte Carlo randomization exact estimate). Since PBMC consist of two clones, where one clone is dominant <a href="#pone.0001831-Lee1" rid="pone.0001831-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698912">[10]</a>, the prediction performance on this data set is similar to the performance on the single clonal data. These significant correlation coefficients suggest that peptide cross-reactivity can, to some degree, be estimated from peptide similarities. Thus the proposed model of peptide similarity is capable of producing significant predictions of the loss of recognition due to single amino acid substitutions. Iversen et al. <a href="#pone.0001831-Iversen1" rid="pone.0001831-Iversen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698909">[18]</a> measured IFN&#x003b3; secretion by T cells specific for SLYNTVATL (SYL9), when they are stimulated with naturally occurring (i.e, patient derived) variants of SYL9. Data consisted of 21 variants of SYL9. Each variant peptide had between 1 and 3 mutations with respect to SYL9. <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002" co-legend-rid="lgnd_pone-0001831-g002"><span>Fig. 2B</span></a> presents a scatter plot of the data from Iversen et al. <a href="#pone.0001831-Iversen1" rid="pone.0001831-Iversen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698907">[18]</a> for the T4 clone, where the peptide similarity is plotted on the y-axis against the relative IFN&#x003b3; secretion (x-axis). Using the BLOSUM35 matrix to calculate the peptide similarity score (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>) the Pearson correlation was 0.65. Similar results were obtained using BLOSUM matrices 35&#x02013;90 (data not shown). For the remaining CTL clones (G10, C-3, C-4, C-22 and C-32) tested by Iversen et al. <a href="#pone.0001831-Iversen1" rid="pone.0001831-Iversen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698906">[18]</a> correlations were 0.49, 0.47, 0.55, 0.60 and 0.57 respectively (all values are significantly different from zero with p&#x0003c;0.02 Monte Carlo randomization exact estimate). This model of peptide similarity (or cross-reactivity) was thus able to explain around 20&#x02212;40&#x00025; of the IFN&#x003b3; secretion. Still, a number of SYL9 variants, for which we predict rather high peptide similarity to SYL9, hardly induce an IFN&#x003b3; response, e.g., A7S, A7V, T5A mutants given in the upper left corner of <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002" co-legend-rid="lgnd_pone-0001831-g002"><span>Fig. 2</span></a>. Part of this discrepancy is due to the fact that our model is not position specific, and thus underestimates the effect of mutations in the central positions, which are crucial for T cell recognition (see <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g001" rid-ob="ob-pone-0001831-g001" co-legend-rid="lgnd_pone-0001831-g001"><span>Fig. 1A</span></a>). When more data becomes available, the peptide similarity model can be extended with a weighting accounting for the relative importance of the peptide positions.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001831-g002" co-legend-rid="lgnd_pone-0001831-g002"><a href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139830891184064" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2263130_pone.0001831.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001831.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2263130/bin/pone.0001831.g002.jpg" /></a></div><div id="largeobj_idm139830891184064" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001831-g002"><div><a class="figpopup" href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Predicting cross-reactivity.</strong><p id="__p11">(A) Box plot of ELISPOT data for the two CTL clones G10 and T4, and PBMC. The x-axis shows the relative IFN&#x003b3; secretion measured for 171 single mutants of SLFNTVATL (SFL9). Immunogenicity was grouped in four bins with average ELISPOT responses of 0, 0.15, 0.50 and 0.85 of maximal ELISPOT for SFL9. In both figures the y-axis shows the predicted CTL recognition in terms of BLOSUM35 similarity scores (see Eq. 2). Unfavorable (non-conservative) substitutions (low x) are associated with a low similarity score (low y) whereas conservative substitutions (high x) in general are associated with higher similarity scores (high y). (B) Observed and predicted recognition of patient derived SLYNTVATL (SYL9) variants with 0&#x02013;3 mutations. The axis shows the relative IFN&#x003b3; and peptide similarity scores. Note, that the IFN&#x003b3; response falls to a half when peptide similarity is around 0.85.</p></div></div></div><p id="__p12" class="p p-last">We were able to achieve similar performances while testing the model on other peptide scanning data, e.g. La Rosa et al. <a href="#pone.0001831-LaRosa1" rid="pone.0001831-LaRosa1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698927">[19]</a> (HLA-A2 restricted CMV epitope, data not shown). Thus, our model was able to predict cross-reactivity of T cell clones measured in at least two different peptide-scanning library studies.</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Analysis of known cross-reactive epitopes</h3><p id="__p13" class="p p-first">Striking examples of T cell cross-reactivity have been reported for CTL responses to viruses <a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698890">[17]</a>, <a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698903">[20]</a>. It was shown that CTLs that were elicited during a primary viral infection might also respond when the same mice are re-infected with unrelated viruses. By mapping the different viral epitopes to which a particular T cell clone can respond, it was demonstrated that these cross-reactive epitopes can share very little sequence identity <a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698905">[17]</a>, <a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698889">[20]</a> leading to the conclusion that CTLs are extremely non-specific <a href="#pone.0001831-Mason1" rid="pone.0001831-Mason1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698904">[8]</a>, <a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698884">[17]</a>, <a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698891">[20]</a>. Reviewing the literature, we compiled a set of 19 cross-reactive epitopes in <a href="/pmc/articles/PMC2263130/table/pone-0001831-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0001831-t001" rid-ob="ob-pone-0001831-t001" co-legend-rid=""><span>Table 1</span></a>. These epitopes are restricted to the K<sup>b</sup>, K<sup>d</sup>, D<sup>b</sup>, HLA-A1, HLA-A2, and HLA-B62 MHC alleles. Some of the epitopes share only a few amino acids; one is even different on all positions, while others share the majority of the amino acids. We assumed that the first epitope (<em>x</em>) in a cross-reactive pair (<em>x,y</em>) is the original epitope for which the cross-reactive CTL clone was first raised, and that it was observed to respond to y later (see <a href="/pmc/articles/PMC2263130/table/pone-0001831-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0001831-t001" rid-ob="ob-pone-0001831-t001" co-legend-rid=""><span>Table 1</span></a>). To test whether these cross-reactive epitopes that differ markedly in their sequence could nevertheless have structurally similar amino acids on the non-identical positions, we did the following. First we computed the similarity of the cross-reactive epitopes <em>S<sub>O</sub></em>. Then we constructed an ensemble of random peptides that have the same identical positions as the cross-reactive epitope pair but otherwise consist of random amino acids (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a> for details). We then computed the baseline (or the expected) peptide-similarity as the average random similarity denoted <em>S<sub>E</sub></em>. In 16 out of 19 pairs the observed similarity <em>S<sub>O</sub></em> exceeded the expected baseline similarity <em>S<sub>E</sub></em> (see <a href="/pmc/articles/PMC2263130/table/pone-0001831-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0001831-t001" rid-ob="ob-pone-0001831-t001" co-legend-rid=""><span>Table 1</span></a> and <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003" co-legend-rid="lgnd_pone-0001831-g003"><span>Fig. 3A</span></a>, p&#x0003c;0.02, Fisher\'s exact test). <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003" co-legend-rid="lgnd_pone-0001831-g003"><span>Fig. 3A</span></a> shows the observed (<em>S<sub>O</sub></em>) versus the baseline expected similarity (<em>S<sub>E</sub></em>) and the solid line presents the case where <em>S<sub>O</sub>&#x0200a;=&#x0200a;S<sub>E</sub></em>. This plot demonstrates that cross-reactive epitopes are significantly more similar than unrelated peptides with the same level of sequence identity. Thus, in cross-reacting T cell ligands non-identical positions are significantly more conservative than random. <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003" co-legend-rid="lgnd_pone-0001831-g003"><span>Fig. 3B</span></a> shows this more explicitly. The 19 epitope pairs were split in two groups according to the level of sequence identity; <em>less than 50&#x00025;</em> and <em>larger than or equal to 50&#x00025;</em> identity. For both groups we compute the <em>percent excess observed similarity</em> of the cross-reactive constituents defined as 100&#x022c5;(<em>S<sub>O</sub></em>&#x02212;<em>S<sub>E</sub></em>)/<em>S<sub>E</sub></em> From <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003" co-legend-rid="lgnd_pone-0001831-g003"><span>Fig. 3</span></a>, we clearly see that for &#x0201c;seemingly&#x0201d; unrelated sequences (identity&#x0003c;50&#x00025;) the excess observed similarity (y-axis) is on average 25.8&#x00025; &#x0002b;/&#x02212; 10.8&#x00025;, i.e., when sequence identity is low, the observed similarity is much higher than the expected similarity. Conversely, for epitopes sharing more than half the amino acids, excess similarity drops markedly (2.0&#x00025; &#x0002b;/&#x02212; 4.3&#x00025;) probably because cross-reactivity is maintained by the more numerous identical positions. The difference in excess observed similarity between the groups is highly significant (p&#x0003c;0.001, rank test), which suggests that amino acid identity is a poor measure for estimating physicochemical similarity, and thus T cell cross-reactivity. In summary, the above results demonstrate that biochemical similarity plays a large role in defining CTL cross-reactivity when sequence identity is low. In such cases, cross-reactivity is observed for non-identical, but conservative, substitutions preserving structural and/or physiochemical properties satisfying the idiosyncratic binding constrains of the responding TCR.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001831-g003" co-legend-rid="lgnd_pone-0001831-g003"><a href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139830932354512" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2263130_pone.0001831.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001831.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2263130/bin/pone.0001831.g003.jpg" /></a></div><div id="largeobj_idm139830932354512" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001831-g003"><div><a class="figpopup" href="/pmc/articles/PMC2263130/figure/pone-0001831-g003/" target="figure" rid-figpopup="pone-0001831-g003" rid-ob="ob-pone-0001831-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Predicted similarity of pairs of cross-reactive epitopes reported in the literature.</strong><p id="__p14">(A) The observed similarities S<sub>O</sub> between 19 cross-reactive epitopes listed in <a href="/pmc/articles/PMC2263130/table/pone-0001831-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0001831-t001" rid-ob="ob-pone-0001831-t001" co-legend-rid=""><span>table 1</span></a> versus the expected similarities S<sub>E</sub> (for definitions of S<sub>E</sub> and S<sub>O</sub> see the text). The line depicts the diagonal S<sub>O</sub>&#x0200a;=&#x0200a;S<sub>E</sub>. 16 out of 19 points fall above the diagonal. (B) The relative increase of observed similarity with respect to the expected similarity. There is a strong inverse relationship between sequence identity and the level of conservation on non-identical positions. Cross-reactive epitopes with low sequence identity share increasingly conserved amino acids on the remaining positions.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0001831-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Examples of cross-reactive epitopes reported in the literature.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139830927382816" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">MHC</td><td align="left" rowspan="1" colspan="1">Initial</td><td align="left" rowspan="1" colspan="1">Subsequent</td><td align="left" rowspan="1" colspan="1">Initial</td><td align="left" rowspan="1" colspan="1">Subsequent</td><td align="left" rowspan="1" colspan="1">Overlap</td><td align="left" rowspan="1" colspan="1">Id</td><td align="left" rowspan="1" colspan="1">S<sub>O</sub>\n</td><td align="left" rowspan="1" colspan="1">S<sub>E</sub>\n</td><td align="left" rowspan="1" colspan="1">Ref.</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">PV NP</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVKYPNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVKFPNM</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVK.PN.</strong>\n</td><td align="left" rowspan="1" colspan="1">6/8</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Brehm1" rid="pone.0001831-Brehm1" class=" bibr popnode">[27]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">VV P1</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVKYPNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>YNSLYPNV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>Y...YPN.</strong>\n</td><td align="left" rowspan="1" colspan="1">4/8</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.68</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode">[17]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">VV P10</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVKYPNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>STLNFNNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.T....NL</strong>\n</td><td align="left" rowspan="1" colspan="1">3/8</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Welsh1" rid="pone.0001831-Welsh1" class=" bibr popnode">[17]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">VV A11R</td><td align="left" rowspan="1" colspan="1">\n<strong>YTVKYPNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>AIVNYANL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>..V.Y.NL</strong>\n</td><td align="left" rowspan="1" colspan="1">4/8</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Kim1" rid="pone.0001831-Kim1" class=" bibr popnode">[28]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">VV A11R</td><td align="left" rowspan="1" colspan="1">\n<strong>AVYNFATC</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>AIVNYANL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>A..N.A..</strong>\n</td><td align="left" rowspan="1" colspan="1">3/8</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.45</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Kim1" rid="pone.0001831-Kim1" class=" bibr popnode">[28]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">LCMV NP</td><td align="left" rowspan="1" colspan="1">VV A11R</td><td align="left" rowspan="1" colspan="1">\n<strong>ISHNFCNL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>AIVNYANL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>...N..NL</strong>\n</td><td align="left" rowspan="1" colspan="1">3/8</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Kim1" rid="pone.0001831-Kim1" class=" bibr popnode">[28]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">RSV5 M2-82</td><td align="left" rowspan="1" colspan="1">RSV M2-71</td><td align="left" rowspan="1" colspan="1">\n<strong>SYIGSINNI</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>EYALGVVGV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.Y.......</strong>\n</td><td align="left" rowspan="1" colspan="1">1/9</td><td align="left" rowspan="1" colspan="1">0.46</td><td align="left" rowspan="1" colspan="1">0.36</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Kulkarni1" rid="pone.0001831-Kulkarni1" class=" bibr popnode">[29]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">CTL agonist (APL)</td><td align="left" rowspan="1" colspan="1">IGRP206-214</td><td align="left" rowspan="1" colspan="1">\n<strong>KYNKANWFL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>VYLKTNVFL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.Y.K.N.FL</strong>\n</td><td align="left" rowspan="1" colspan="1">5/9</td><td align="left" rowspan="1" colspan="1">0.6</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Wong1" rid="pone.0001831-Wong1" class=" bibr popnode">[30]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">H2-Kd</td><td align="left" rowspan="1" colspan="1">Dengue 2 NS3-298</td><td align="left" rowspan="1" colspan="1">Dengue 3 NS3-299</td><td align="left" rowspan="1" colspan="1">\n<strong>GYISTRVEM</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>GYISTRVGM</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>GYISTRV.M</strong>\n</td><td align="left" rowspan="1" colspan="1">8/9</td><td align="left" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Spaulding1" rid="pone.0001831-Spaulding1" class=" bibr popnode">[31]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">EBV BMLF1-280</td><td align="left" rowspan="1" colspan="1">FLU A M1-58</td><td align="left" rowspan="1" colspan="1">\n<strong>GLCTLVAML</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>GILGFVFTL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>G....V..L</strong>\n</td><td align="left" rowspan="1" colspan="1">3/9</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">0.47</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Clute1" rid="pone.0001831-Clute1" class=" bibr popnode">[32]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">EBV BMLF1-280</td><td align="left" rowspan="1" colspan="1">FLU A NP-85</td><td align="left" rowspan="1" colspan="1">\n<strong>GLCTLVAML</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>KLGEFYNQM</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.L.......</strong>\n</td><td align="left" rowspan="1" colspan="1">1/9</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode">[20]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">EBV BMLF1-280</td><td align="left" rowspan="1" colspan="1">EBV LMP2</td><td align="left" rowspan="1" colspan="1">\n<strong>GLCTLVAML</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>LLWTLVVLL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.L.TLV..L</strong>\n</td><td align="left" rowspan="1" colspan="1">5/9</td><td align="left" rowspan="1" colspan="1">0.62</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode">[20]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">EBV BMLF1-280</td><td align="left" rowspan="1" colspan="1">EBV BRLF1</td><td align="left" rowspan="1" colspan="1">\n<strong>GLCTLVAML</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>YVLDHLIVV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.........</strong>\n</td><td align="left" rowspan="1" colspan="1">0/9</td><td align="left" rowspan="1" colspan="1">0.32</td><td align="left" rowspan="1" colspan="1">0.22</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode">[20]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">FLU A NA-231</td><td align="left" rowspan="1" colspan="1">HCV NS3-1073</td><td align="left" rowspan="1" colspan="1">\n<strong>CVNGSCFTL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>CVNGVCWTV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>CVNG.C.T.</strong>\n</td><td align="left" rowspan="1" colspan="1">6/9</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1">0.78</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Wedemeyer1" rid="pone.0001831-Wedemeyer1" class=" bibr popnode">[33]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">FLU A M1-58</td><td align="left" rowspan="1" colspan="1">EBV EBNA3A-596</td><td align="left" rowspan="1" colspan="1">\n<strong>GILGFVFTL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>SVRDRLARL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>........L</strong>\n</td><td align="left" rowspan="1" colspan="1">1/9</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1">0.29</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Selin1" rid="pone.0001831-Selin1" class=" bibr popnode">[20]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">HPV 16 E7-11</td><td align="left" rowspan="1" colspan="1">Coronavirus NS2-52</td><td align="left" rowspan="1" colspan="1">\n<strong>YMLDLQPET</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>TMLDIQPED</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.MLD.QPE.</strong>\n</td><td align="left" rowspan="1" colspan="1">6/9</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.76</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Nilges1" rid="pone.0001831-Nilges1" class=" bibr popnode">[34]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A2</td><td align="left" rowspan="1" colspan="1">HIV ENV GP-120</td><td align="left" rowspan="1" colspan="1">M. tuberculosis</td><td align="left" rowspan="1" colspan="1">\n<strong>VPTDPNPPEV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>VLTDGNPPEV</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>V.TD.NPPEV</strong>\n</td><td align="left" rowspan="1" colspan="1">8/10</td><td align="left" rowspan="1" colspan="1">0.79</td><td align="left" rowspan="1" colspan="1">0.8</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Hohn1" rid="pone.0001831-Hohn1" class=" bibr popnode">[35]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-B62</td><td align="left" rowspan="1" colspan="1">Dengue 2 NS3-71</td><td align="left" rowspan="1" colspan="1">Dengue 3 NS3-71</td><td align="left" rowspan="1" colspan="1">\n<strong>DVKKDLISY</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>SVKKDLISY</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>.VKKDLISY</strong>\n</td><td align="left" rowspan="1" colspan="1">8/9</td><td align="left" rowspan="1" colspan="1">0.92</td><td align="left" rowspan="1" colspan="1">0.9</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-Zivny1" rid="pone.0001831-Zivny1" class=" bibr popnode">[36]</a>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">HLA-A1</td><td align="left" rowspan="1" colspan="1">Hantaanvirus (Sin)</td><td align="left" rowspan="1" colspan="1">Hantaanvirus (Seoul)</td><td align="left" rowspan="1" colspan="1">\n<strong>ISNQEPLKL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>ISNQEPMKL</strong>\n</td><td align="left" rowspan="1" colspan="1">\n<strong>ISNQEP.KL</strong>\n</td><td align="left" rowspan="1" colspan="1">8/9</td><td align="left" rowspan="1" colspan="1">0.97</td><td align="left" rowspan="1" colspan="1">0.93</td><td align="left" rowspan="1" colspan="1">\n<a href="#pone.0001831-VanEpps1" rid="pone.0001831-VanEpps1" class=" bibr popnode">[37]</a>\n</td></tr></tbody></table></div><div id="largeobj_idm139830927382816" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2263130/table/pone-0001831-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><p id="__p15" class="p p-first-last">The columns are as follows: 1) MHC restriction, 2) source pathogen and protein for initial infection, 3) source pathogen and protein for subsequent infection, 4) original epitope of initial infection, 5) cross-reactive epitope for subsequent infection, 6) sequence overlap between the cross-reactive epitopes, 7) sequence identity (Id), 8) observed peptide similarity <em>S<sub>O</sub></em> and 9) expected peptide similarity <em>S<sub>E</sub></em> (for definitions of <em>S<sub>O</sub></em> and <em>S<sub>E</sub></em> see the main text) 10) reference to the experimental work. Some infectious agents are indicated with abbreviated names and these are: LCMV: Lymphocytic choriomeningitis virus, PV: Pichinde virus (PV), VV: Vacinia virus, EBV: Epstein-Barr virus, RSV: Respiratory synthical virus, HCV: Hepatitic C virus, and HPV: Human papiloma virus.</p></div></div></div></div><div id="s2f" class="sec sec-last"><h3 id="s2ftitle">Non-immunogenic HIV peptides tend to be more similar to human self-antigens</h3><p id="__p16" class="p p-first">Another open question in T cell response is why roughly half of all foreign cell surface-presented antigens fail to raise a T cell response <a href="#pone.0001831-Yewdell1" rid="pone.0001831-Yewdell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698911">[3]</a>, <a href="#pone.0001831-Assarsson1" rid="pone.0001831-Assarsson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698920">[4]</a>, <a href="#pone.0001831-Lauemoller1" rid="pone.0001831-Lauemoller1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698929">[21]</a>. Tolerance to self-antigens could explain this lack of immunogenicity, in which case the degree of similarity to self-antigens should predict which foreign antigens are likely to be non-immunogenic. We examined this effect of self-tolerance on immunogenecity using our cross-reactivity model. First, a large set of self-antigens was defined, and secondly, a list of non-self (e.g., HIV) antigens was built, labeled as either immunogenic or non-immunogenic according to experimental evidence (data obtained from the Los Alamos HIV database, see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>). The expectation was that T cell clones, with high affinity for HIV peptides similar to self peptide(s), have been tolerized during thymic education via negative selection <a href="#pone.0001831-Huseby1" rid="pone.0001831-Huseby1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698914">[22]</a>, <a href="#pone.0001831-Casanova1" rid="pone.0001831-Casanova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698910">[23]</a>. Such TCRs should therefore not be present in the functional T cell repertoire thus causing tolerance to molecular mimics of self-peptides. We define a score of cross-reactivity to self as the maximum peptide similarity between the non-self antigen and the set of all self-antigens (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>) and test whether non-immunogenic peptides have a higher cross-reactivity score to self when compared to immunogenic ones. We downloaded the human proteome from the NCBI website and identified a set of 230,460 potential HLA-A2 self-antigens (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>). Next, we downloaded the HIV proteome from the Los Alamos HIV database and predicted a set of potential HLA-A2 epitopes. 33 of the 91 predicted HIV candidate epitopes were annotated as A2 supertype restricted epitopes in the Los Alamos database of CTL HIV epitopes, while the remaining 54 of the HIV peptides were never identified as epitopes. Another four peptides were found to be immunogenic for other HLA alleles than HLA-A2. Since it would be wrong to tag these epitopes as &#x0201c;non-immunogenic&#x0201d;, they were excluded from the data set. The 33 confirmed HLA-A2 epitopes were labeled: <em>confirmed HIV epitopes</em> and the remaining 54 possible non-immunogenic peptides were given the label: <em>putative, non-immunogenic HIV peptides</em>. It is possible that future studies reveal that a number of the putative non-immunogenic HIV peptides do in fact elicit CTL responses in HLA-A2<sup>&#x0002b;</sup> patients. Nevertheless, this set of HIV peptides should be enriched in HIV peptides that fail to generate CTL responses. Maximal similarity scores were computed between all 87 HIV peptides (33 immunogens and 54 putative non-immunogens) and the set of 230,460 predicted HLA-A2 self-epitopes. <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g004" rid-ob="ob-pone-0001831-g004" co-legend-rid="lgnd_pone-0001831-g004"><span>Fig. 4</span></a> shows a scatter plot of the 33 HIV immunogens (black diamonds) and 54 putative non-immunogens (open circles). The x-axis shows the predicted antigen presentation score (NetCTL) while the y-axis shows the estimated maximum similarity to the self-antigens <em>S<sub>SELF</sub>(x,y)</em> (see <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>). Immunogenic peptides tend to be less self-like, although the difference between immunogens and non-immunogens is not significant (p&#x0200a;=&#x0200a;0.2, Mann-Whitney). Drawing a horizontal line at y&#x0200a;=&#x0200a;0.85 separates the most self-similar HIV antigens from the rest (the results presented in <a href="/pmc/articles/PMC2263130/figure/pone-0001831-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0001831-g002" rid-ob="ob-pone-0001831-g002" co-legend-rid="lgnd_pone-0001831-g002"><span>Fig. 2B</span></a> suggest that IFN&#x003b3; response would fall to a half when the similarity drops to 85&#x00025;.) For the antigens that have a self-similarity score above 0.85, most (14/16) are classified as non-immunogenic HIV antigens i.e. predicted epitopes not confirmed by experimental evidence (p-value&#x0003c;0.05, Fisher\'s exact test). Note, that the NetCTL score does not correlate with the maximal self-similarity score (p-value&#x0200a;=&#x0200a;0.42, exact estimate) and the above difference between the immunogenic and non-immunogenic antigens is therefore not explained by the difference in the NetCTL scores. Repeating our analysis for HLA-A3 and HLA-B7, we found similar tendency of more-self-likeness among non-immunogenic HIV-1 peptides (p&#x0003c;0.3 and p&#x0003c;0.45 respectively). Summarizing, these results suggest that similarity to self-antigens plays a role in discriminating immunodominant from cryptic peptides.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0001831-g004" co-legend-rid="lgnd_pone-0001831-g004"><a href="/pmc/articles/PMC2263130/figure/pone-0001831-g004/" target="figure" rid-figpopup="pone-0001831-g004" rid-ob="ob-pone-0001831-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139830854990144" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2263130_pone.0001831.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001831.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2263130/bin/pone.0001831.g004.jpg" /></a></div><div id="largeobj_idm139830854990144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2263130/figure/pone-0001831-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0001831-g004"><div><a class="figpopup" href="/pmc/articles/PMC2263130/figure/pone-0001831-g004/" target="figure" rid-figpopup="pone-0001831-g004" rid-ob="ob-pone-0001831-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>HIV self-similarity and immunogenicity.</strong><p id="__p17">The NetCTL antigen presentation score (x-axis) and maximal self-similarity (y-axis). Confirmed HIV epitopes are shown as black diamonds and predicted, non-immunogenic HIV peptides are shown as open circles. The 0.85 self-similarity line described in the text divides the y-axis. The region above the line is clearly dominated by non-immunogenic antigens where 88&#x00025; (14/16) are non-immunogenic compared to the expected frequency of 62&#x00025; (54/87). This difference is significant (p&#x0003c;0.05, Fisher\'s exact test). Peptide similarity was calculated using the BLOSUM35 matrix.</p></div></div></div></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Discussion</h2><p id="__p18" class="p p-first">Many studies have suggested that T cells can recognize totally unrelated peptides and a new term, <strong>poly-specificity</strong> was coined to express the high specificity of T cell receptors to unrelated peptides <a href="#pone.0001831-Wucherpfennig1" rid="pone.0001831-Wucherpfennig1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698897">[6]</a>. The &#x0201c;unrelatedness&#x0201d; of the peptides was defined as low sequence identity, however, sequence identity might not be able to account for the total amount of structural similarity that drives TCR recognition. Here, we demonstrate that this is indeed the case: T cell receptors recognize biochemically and structurally related peptides and cross-reactivity is, up to a degree, predictable. The loss of recognition simply depends on the number and similarity of non-identical amino acid between cross-reactive constituents. We find that the majority of the seemingly &#x0201c;unrelated&#x0201d; cross-reactive peptides have a significantly higher biochemical similarity to each other than what would be expected from truly &#x0201c;unrelated&#x0201d; peptides. This is especially true for peptides with very limited identity. To our knowledge this is the first study that analyzes a large set of cross-reactive peptide-MHC combinations and demonstrates that the cross-reactivity can, up to a certain extent, be predicted.</p><p id="__p19">Because negative selection of immature thymocytes remove high affinity TCR specific for self-antigens <a href="#pone.0001831-Felix1" rid="pone.0001831-Felix1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698892">[7]</a>, we expected that this should leave a &#x0201c;hole&#x0201d; in the T cell repertoire around negative selecting self-antigens. Hence, if an infected cell presents a nonself antigen that is highly similar to a negative selecting self-antigen, then this foreign antigen might not be matched by any available TCR which could provide an explanation for why around half of foreign pMHC do not generate a T cell response <a href="#pone.0001831-Yewdell1" rid="pone.0001831-Yewdell1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698896">[3]</a>, <a href="#pone.0001831-Assarsson1" rid="pone.0001831-Assarsson1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698918">[4]</a>, <a href="#pone.0001831-Lauemoller1" rid="pone.0001831-Lauemoller1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698895">[21]</a>. We tested this hypothesis for HLA-A2 restricted HIV-1 response and showed that the absence of T cell response to part of the non-confirmed (i.e. putative non-immunogenic) HLA-A2 restricted HIV-1 peptides can be explained by their similarity to self antigens. These results are in agreement with a recent study by Rolland et al. <a href="#pone.0001831-Rolland1" rid="pone.0001831-Rolland1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698926">[24]</a>, who showed a trend of more-self-likeness (measured in terms of number of shared amino acids) among HIV peptides with no detectable CTL responses in a large study group. We predict that the correlation found by Rolland et al. would be stronger if amino acid similarity is taken into account.</p><p id="__p20">If peptide similarity can be used to describe T cell reactivity, what would then be the best model to describe similar peptides? We have chosen for the simplest model (given by Eq. (2) in <a href="#s4" rid="s4" class=" sec">Materials and Methods</a>) because systemic data on cross-reactive peptides is very limited. An obvious extension of this model would be to add position dependence, i.e., account for the fact that central positions play a larger role.</p><p id="__p21" class="p p-last">The number of potential antigens exceeds the number of T cells in the immune system and the ability to recognize multiple ligands is required to mount at least a few responses to all potential pathogens <a href="#pone.0001831-Mason1" rid="pone.0001831-Mason1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698885">[8]</a>. Here, we demonstrate that the number of expected T cell ligands is not necessarily reduced by restricting T cell recognition to cover only similar peptides: it is still possible for a T cell to recognize 10<sup>5</sup>&#x02212;10<sup>6</sup> peptides. These estimates of the complexity of CTL recognition are well within the bounds of earlier estimates <a href="#pone.0001831-Mason1" rid="pone.0001831-Mason1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698888">[8]</a>. In summary, the results presented here quantify, to our knowledge for the first time, that the basis of T cell recognition is amino acid similarity, defined in terms of biochemical properties of amino acid side chains.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Materials and Methods</h2><div id="s4a" class="sec sec-first"><h3 id="s4atitle">TCR binding motif</h3><p id="__p22" class="p p-first-last">Lee et al. <a href="#pone.0001831-Lee1" rid="pone.0001831-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698899">[10]</a> analyzed the specificity of CTL responses against the immunodominant HLA-A2 restricted HIV Gag epitope SLFNTVATL (SFL9). IFN&#x003b3; production was measured in response against all 171 single mutant variants of SFL9 for two T cell clones (G10 and T4), and for purified Peripheral Blood Mononuclear Cells (PMBCs) using an ELISPOT assay. Purified PBMCs consisted of just two clones where one was dominant. CTL responses were reported as the percentage of maximal IFN&#x003b3; (I) obtained for the reference ELISPOT of SFL9 and discretized in five intervals: ]0;30], ]31;70], ]70;100[and 100&#x00025;. We replaced each interval by the interval midpoint, translating the original data to the real values: 0.00, 0.15, 0.50, 0.85 and 1.00 respectively. We defined a measure of the &#x0201c;relative frequency of recognition&#x0201d;, <em>f<sub>i,a</sub></em>, for a variant carrying mutation <em>a</em> on position <em>i</em>, as the response of the variant, divided by the total of all variants on the same position as:</p><div class="disp-formula"><div class="f"><img src="/pmc/articles/PMC2263130/bin/pone.0001831.e001.jpg" class="eq-image" alt="equation image" title="equation image" /></div></div><p>\n</p></div><div id="s4b" class="sec"><h3 id="s4btitle">Simpson index</h3><p id="__p23" class="p p-first-last">To measure the diversity at position <em>i</em> in an alignment, we define <em>D(i)&#x0200a;=&#x0200a;1/S(i),</em> where <em>S</em>(<em>i</em>)&#x0200a;=&#x0200a;&#x003a3;<sup>20</sup>\n<em><sub>a</sub></em>\n<sub>&#x0200a;=&#x0200a;1</sub>(<em>p<sub>i,a</sub></em>)<sup>2</sup> is the Simpson index. Here, <em>p<sub>i,a</sub></em> is the probability that a particular amino acids occurs at position <em>i</em> in the alignment where &#x003a3;<sup>20</sup>\n<em><sub>a</sub></em>\n<sub>&#x0200a;=&#x0200a;1</sub>\n<em>p<sub>i,a</sub></em>&#x0200a;=&#x0200a;1. In all cases <em>p<sub>i,a</sub></em>&#x0200a;=&#x0200a;<em>f<sub>i,a</sub></em> (see above definition). If position <em>i</em> is fully conserved, then <em>D(i)&#x0200a;=&#x0200a;1</em>, if all amino acids occur with equal frequency i.e. <em>p<sub>i,a</sub></em>&#x0200a;=&#x0200a;1/20, then <em>D(i)&#x0200a;=&#x0200a;20</em>.</p></div><div id="s4c" class="sec"><h3 id="s4ctitle">Peptide similarity score</h3><p id="__p24" class="p p-first">The un-normalized peptide similarity score <em>A(x,y)</em> between reference epitope: <em>x</em>&#x0200a;=&#x0200a;{<em>x</em>\n<sub>1</sub>, L, <em>x</em>\n<sub>N</sub>} and peptide: <em>y</em>&#x0200a;=&#x0200a;{<em>y</em>\n<sub>1</sub>, L, <em>y</em>\n<sub>N</sub>} of the same length <em>N</em> is defined as the sum of substitution scores along the sequences expressed by the relation:</p><div class="disp-formula"><div class="f"><img src="/pmc/articles/PMC2263130/bin/pone.0001831.e002.jpg" class="eq-image" alt="equation image" title="equation image" /></div><div class="l">(1)</div></div><p>\n<em><sub>W</sub></em>\n<sub>(<em>xi</em>, <em>yi</em>)</sub> is the amino acid substitution matrix, e.g., BLOSUM35, providing a measure of how conservative substitutions are. The peptide-similarity score for the reference peptide <em>x</em> spans the interval: <em>I<sup>x</sup></em>&#x0200a;=&#x0200a;[<em>A<sup>x</sup></em>\n<sub>min</sub>; <em>A<sup>x</sup></em>\n<sub>max</sub>] where the length of the interval <em>|I|&#x0200a;=&#x0200a;A</em>\n<sub>max</sub>&#x02212;<em>A</em>\n<sub>min</sub> depends on references peptide <em>x</em> and matrix <em>W</em>. Two different intervals (<em>I<sup>x</sup>, I<sup>y</sup></em>\n<sup>&#x02260;<em>x</em></sup>) are not comparable <em>per se</em>. Thus, we define the normalized peptide similarity using the relation</p><div class="disp-formula"><div class="f"><img src="/pmc/articles/PMC2263130/bin/pone.0001831.e003.jpg" class="eq-image" alt="equation image" title="equation image" /></div><div class="l">(2)</div></div><p>\n</p><p id="__p25" class="p p-last">This equation constitutes the model of peptide similarity used throughout subsequent analysis. <em>S(x,y)</em> measures how much peptide <em>y</em> resembles <em>x</em> in terms of the number and magnitude of conservative substitutions. <em>A<sup>x</sup></em>\n<sub>max</sub> is the auto-peptide-similarity score of <em>x</em>. Thus, <em>A<sup>x</sup></em>\n<sub>max</sub>&#x0200a;=&#x0200a;<em>A(x,x)</em>. If peptide <em>y</em> is a mimic of <em>x</em> then <em>S(x,y)</em> should be close to 1. The other extreme value (<em>A<sup>x</sup></em>\n<sub>min</sub>) is found by comparing <em>x</em> with a peptide <em><math><mover accent="true"><mi>&#x078;</mi><mo>&#x0305;</mo></mover></math></em>, where on each position the amino acid in <em><math><mover accent="true"><mi>&#x078;</mi><mo>&#x0305;</mo></mover></math></em> corresponds to the substitution in <em>x</em> with the smallest value i.e. the least likely substitution. In this way 0&#x02264;<em>S</em>(<em>x</em>,<em>y</em>)&#x02264;1 for all peptides <em>y</em>. The peptide-similarity score is asymmetric i.e. <em>S</em>(<em>a</em>,<em>b</em>)&#x02260;<em>S</em>(<em>b</em>,<em>a</em>) despite <em>W</em> being symmetric. The reason is that the extreme values (<em>A</em>\n<sub>min</sub>,<em>A</em>\n<sub>max</sub>) cannot be guarantied to be identical for any pair of peptides (<em>a,b</em>). Reference peptides <em>x</em> which are dominated by amino acids like tryptophan that hardly ever substitute, will have few highly similar peptides (<em>y</em>) which satisfy the condition: <em>S(x,y) &#x02248; 1</em>. In contrast, reference peptides which are enriched in amino acids that are more likely to substitute (given the matrix <em>W</em>) have a greater number of highly similar peptides. This property is captured by the asymmetry of <em>S.</em>\n</p></div><div id="s4d" class="sec"><h3 id="s4dtitle">Expected baseline similarity between primary epitopes and presumably unrelated peptides</h3><p id="__p26" class="p p-first-last">The observed similarity <em>S<sub>O</sub></em> of pairs of experimentally verified cross-reactive epitopes (<em>x,y</em>) is to be compared to unrelated peptides <em>(z<sub>i</sub></em>) which retain the sequence identity of (x,y) but have an otherwise random amino acid on non-identical positions. The procedure to compute the &#x0201c;unrelated&#x0201d; or &#x0201c;baseline&#x0201d; expected similarity is best illustrated by an example: The HLA-A2 epitopes <em>x</em>&#x0200a;=&#x0200a;<span class="underline">G</span>LCTL<span class="underline">V</span>AM<span class="underline">L</span> and <em>y</em>&#x0200a;=&#x0200a;<span class="underline">G</span>ILGF<span class="underline">V</span>FT<span class="underline">L</span> from EBV and influenza-A share 3 identical positions: G1, V6 and L9. We first compute the observed similarity <em>S<sub>O</sub>&#x0200a;=&#x0200a;S(x,y)</em> between epitopes <em>x</em> and <em>y</em> using Eq. (2). Then we generate a set of <em>N&#x0200a;=&#x0200a;10.000</em> random peptides, <em>z</em>\n<sup>1</sup>, <em>z</em>\n<sup>2</sup>, L, <em>z<sup>N</sup></em>, with the same identical positions, i.e. we have <em>z<sub>i</sub></em>&#x0200a;=&#x0200a;G&#x02026;&#x02026;V&#x02026;L where a dot can be any amino acids avoiding identity with <em>x</em> at that position. The expected similarity between the primary (original) epitope (<em>x</em>) and the unrelated but semi-identical artificial peptides <em>z</em> is then defined as the average similarity to the ensemble of unrelated peptides as: <img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0001831.e004.jpg" src="/pmc/articles/PMC2263130/bin/pone.0001831.e004.jpg" class="equation" />.</p></div><div id="s4e" class="sec"><h3 id="s4etitle">Non-immunogenic HIV-peptides (HLA-A2)</h3><p id="__p27" class="p p-first-last">The HIV-1 HXB2 sequence for Env, Pol, Vpu, Rev, Tat, Vif, Vpr, p17, p24 and p2p7p1p6 and the HIV-1 clade B consensus sequence for Nef (due to a stop codon in HXB2-Nef) were downloaded from the Los Alamos database (<a href="http://www.hiv.lanl.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.hiv.lanl.gov</a>). There was also one stop codon in HXB2 sequence for TAT, however, no TAT peptides were predicted to be HLA-A2 epitopes and thus the stop codon did not interfere with our results. Out of 3,063 HIV nonamers, 91 were predicted to be HLA-A2 epitopes using NetCTL version 1.2 <a href="#pone.0001831-Larsen1" rid="pone.0001831-Larsen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698898">[25]</a>, <a href="#pone.0001831-Larsen2" rid="pone.0001831-Larsen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698930">[26]</a> and default selection threshold (0.75). NetCTL predicts the level of antigen presentation by combining three separate predictions of: proteasomal cleavage, TAP affinity and MHC biding. Four out of the 91 predicted HIV epitopes were found to be immunogenic for other supertypes than HLA-A2 and were filtered out. These were: QLQARILAV, RILAVERYL (class II, DPW4.2), TLYCVHQRI (HLA-A11) and SINNETPGI (HLA-A25). Of the remaining 91-4&#x0200a;=&#x0200a;87 peptides, 33 were confirmed HLA-A2 epitopes by cross-referencing the records of the LANL CTL epitope summary table (downloaded December 2006). Thus, the epitope prediction resulted in the identification of 87 possible HLA-A2 restricted HIV epitopes where 33 (38&#x00025;) were confirmed and 54 (62&#x00025;) were not.</p></div><div id="s4f" class="sec"><h3 id="s4ftitle">Human HLA-A2 restricted self-antigens</h3><p id="__p28" class="p p-first-last">The human proteome was downloaded from the NCBI website (<a href="http://www.ncbi.nlm.nih.gov/Genomes/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.ncbi.nlm.nih.gov/Genomes/</a> date: 29 march 2006) and contained 34.460 protein sequences. The removal of proteins containing the words: <em>predicted</em>, <em>hypothetic</em> or <em>isoform</em> in the protein description label lead to a final core human proteome of 14,034 human protein sequences. We predicted A2 self-antigens using NetCTL version 1.2 <a href="#pone.0001831-Larsen1" rid="pone.0001831-Larsen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698900">[25]</a>, <a href="#pone.0001831-Larsen2" rid="pone.0001831-Larsen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_665698894">[26]</a> for all these protein sequences (default epitope selection threshold). Repeats were removed, along with a small set of self-peptides, which contained the unknown amino acid (X). The final set consisted of 230,460 predicted human HLA-A2 restricted self-antigens each of length 9.</p></div><div id="s4g" class="sec sec-last"><h3 id="s4gtitle">HIV self-similarity (HLA-A2)</h3><p id="__p29" class="p p-first-last">The maximal similarity between predicted HIV antigens (<em>x</em>) and the set of human 230,460 self-antigens (<em>y</em>) was defined as the self-similarity score <em>S<sub>self</sub></em>(<em>x</em>)&#x0200a;=&#x0200a;max(<em>S</em>(<em>x</em>,<em>y</em>)) for HIV peptide <em>x</em>. Self-similarity scores were obtained for all confirmed HIV epitopes and putative HIV antigens. Because no identical matches were found between HIV epitopes and self-antigens, self-similarity scores were always <em>S(x,y)&#x0003c;1</em>. Confirmed HIV epitopes and putative non-immunogenic HIV peptides were ranked on maximum self-similarity, and the combined ranking was split in two parts: a) The peptides with a self-similarity score greater than 0.85 and b) and peptide with a self-similarity score below 0.85. We used Fisher\'s exact test to compute the significance of the difference in the frequency of putative HIV epitopes in the top versus the bottom.</p></div></div><div id="idm139830857322144" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139830857322144title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139830857322016"><p id="__p30" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm139830857320896"><p id="__p31" class="p p-first-last"><strong>Funding: </strong>This work was supported by NIAID Contract no. HHSN266200400083C. The principal funding recipient was Prof. Ole Lund (Technical University of Denmark).</p></p></div></div><div id="idm139830857319616" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139830857319616title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0001831-Moutaftsi1">1. <span class="element-citation">Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, et al.  A consensus epitope prediction approach identifies the breadth of murine T(CD8&#x0002b;)-cell responses to vaccinia virus. <span><span class="ref-journal">Nat Biotechnol. </span>2006;<span class="ref-vol">24</span>:817\xe2\x80\x93819.</span> [<a href="/pubmed/16767078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Biotechnol&amp;title=A+consensus+epitope+prediction+approach+identifies+the+breadth+of+murine+T(CD8&#x0002b;)-cell+responses+to+vaccinia+virus.&amp;author=M+Moutaftsi&amp;author=B+Peters&amp;author=V+Pasquetto&amp;author=DC+Tscharke&amp;author=J+Sidney&amp;volume=24&amp;publication_year=2006&amp;pages=817-819&amp;pmid=16767078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Peters1">2. <span class="element-citation">Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, et al.  A community resource benchmarking predictions of peptide binding to MHC-I molecules. <span><span class="ref-journal">PLoS Comput Biol. </span>2006;<span class="ref-vol">2</span>:e65.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1475712/">PMC free article</a>]</span> [<a href="/pubmed/16789818" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Comput+Biol&amp;title=A+community+resource+benchmarking+predictions+of+peptide+binding+to+MHC-I+molecules.&amp;author=B+Peters&amp;author=HH+Bui&amp;author=S+Frankild&amp;author=M+Nielson&amp;author=C+Lundegaard&amp;volume=2&amp;publication_year=2006&amp;pages=e65&amp;pmid=16789818&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Yewdell1">3. <span class="element-citation">Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. <span><span class="ref-journal">Annual Review of Immunology. </span>1999;<span class="ref-vol">17</span>:51\xe2\x80\x9388.</span> [<a href="/pubmed/10358753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annual+Review+of+Immunology&amp;title=Immunodominance+in+major+histocompatibility+complex+class+I-restricted+T+lymphocyte+responses.&amp;author=JW+Yewdell&amp;author=JR+Bennink&amp;volume=17&amp;publication_year=1999&amp;pages=51-88&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Assarsson1">4. <span class="element-citation">Assarsson E, Sidney J, Oseroff C, Pasquetto V, Bui HH, et al.  A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. <span><span class="ref-journal">J Immunol. </span>2007;<span class="ref-vol">178</span>:7890\xe2\x80\x937901.</span> [<a href="/pubmed/17548627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=A+quantitative+analysis+of+the+variables+affecting+the+repertoire+of+T+cell+specificities+recognized+after+vaccinia+virus+infection.&amp;author=E+Assarsson&amp;author=J+Sidney&amp;author=C+Oseroff&amp;author=V+Pasquetto&amp;author=HH+Bui&amp;volume=178&amp;publication_year=2007&amp;pages=7890-7901&amp;pmid=17548627&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Rudolph1">5. <span class="element-citation">Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. <span><span class="ref-journal">Annu Rev Immunol. </span>2006;<span class="ref-vol">24</span>:419\xe2\x80\x93466.</span> [<a href="/pubmed/16551255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=How+TCRs+bind+MHCs,+peptides,+and+coreceptors.&amp;author=MG+Rudolph&amp;author=RL+Stanfield&amp;author=IA+Wilson&amp;volume=24&amp;publication_year=2006&amp;pages=419-466&amp;pmid=16551255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Wucherpfennig1">6. <span class="element-citation">Wucherpfennig KW, Allen PM, Celada F, Cohen IR, De Boer R, et al.  Polyspecificity of T cell and B cell receptor recognition. <span><span class="ref-journal">Semin Immunol. </span>2007;<span class="ref-vol">19</span>:216\xe2\x80\x93224.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2034306/">PMC free article</a>]</span> [<a href="/pubmed/17398114" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Semin+Immunol&amp;title=Polyspecificity+of+T+cell+and+B+cell+receptor+recognition.&amp;author=KW+Wucherpfennig&amp;author=PM+Allen&amp;author=F+Celada&amp;author=IR+Cohen&amp;author=R+De+Boer&amp;volume=19&amp;publication_year=2007&amp;pages=216-224&amp;pmid=17398114&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Felix1">7. <span class="element-citation">Felix NJ, Donermeyer DL, Horvath S, Walters JJ, Gross ML, et al.  Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. <span><span class="ref-journal">Nat Immunol. </span>2007;<span class="ref-vol">8</span>:388\xe2\x80\x93397.</span> [<a href="/pubmed/17322886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=Alloreactive+T+cells+respond+specifically+to+multiple+distinct+peptide-MHC+complexes.&amp;author=NJ+Felix&amp;author=DL+Donermeyer&amp;author=S+Horvath&amp;author=JJ+Walters&amp;author=ML+Gross&amp;volume=8&amp;publication_year=2007&amp;pages=388-397&amp;pmid=17322886&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Mason1">8. <span class="element-citation">Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. <span><span class="ref-journal">Immunol Today. </span>1998;<span class="ref-vol">19</span>:395\xe2\x80\x93404.</span> [<a href="/pubmed/9745202" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Today&amp;title=A+very+high+level+of+crossreactivity+is+an+essential+feature+of+the+T-cell+receptor.&amp;author=D+Mason&amp;volume=19&amp;publication_year=1998&amp;pages=395-404&amp;pmid=9745202&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Hemmer1">9. <span class="element-citation">Hemmer B, Vergelli M, Gran B, Ling N, Conlon P, et al.  Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. <span><span class="ref-journal">J Immunol. </span>1998;<span class="ref-vol">160</span>:3631\xe2\x80\x933636.</span> [<a href="/pubmed/9558061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Predictable+TCR+antigen+recognition+based+on+peptide+scans+leads+to+the+identification+of+agonist+ligands+with+no+sequence+homology.&amp;author=B+Hemmer&amp;author=M+Vergelli&amp;author=B+Gran&amp;author=N+Ling&amp;author=P+Conlon&amp;volume=160&amp;publication_year=1998&amp;pages=3631-3636&amp;pmid=9558061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Lee1">10. <span class="element-citation">Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, et al.  T cell cross-reactivity and conformational changes during TCR engagement. <span><span class="ref-journal">J Exp Med. </span>2004;<span class="ref-vol">200</span>:1455\xe2\x80\x931466.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2211951/">PMC free article</a>]</span> [<a href="/pubmed/15583017" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=T+cell+cross-reactivity+and+conformational+changes+during+TCR+engagement.&amp;author=JK+Lee&amp;author=G+Stewart-Jones&amp;author=T+Dong&amp;author=K+Harlos&amp;author=K+Di+Gleria&amp;volume=200&amp;publication_year=2004&amp;pages=1455-1466&amp;pmid=15583017&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Schneider1">11. <span class="element-citation">Schneider TD, Stephens RM. Sequence logos: a new way to display consensus sequences. <span><span class="ref-journal">Nucleic Acids Res. </span>1990;<span class="ref-vol">18</span>:6097\xe2\x80\x936100.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC332411/">PMC free article</a>]</span> [<a href="/pubmed/2172928" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=Sequence+logos:+a+new+way+to+display+consensus+sequences.&amp;author=TD+Schneider&amp;author=RM+Stephens&amp;volume=18&amp;publication_year=1990&amp;pages=6097-6100&amp;pmid=2172928&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Garcia1">12. <span class="element-citation">Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, et al.  An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. <span><span class="ref-journal">Science. </span>1996;<span class="ref-vol">274</span>:209\xe2\x80\x93219.</span> [<a href="/pubmed/8824178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=An+alphabeta+T+cell+receptor+structure+at+2.5+A+and+its+orientation+in+the+TCR-MHC+complex.&amp;author=KC+Garcia&amp;author=M+Degano&amp;author=RL+Stanfield&amp;author=A+Brunmark&amp;author=MR+Jackson&amp;volume=274&amp;publication_year=1996&amp;pages=209-219&amp;pmid=8824178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Arden1">13. <span class="element-citation">Arden B. Conserved motifs in T-cell receptor CDR1 and CDR2: implications for ligand and CD8 co-receptor binding. <span><span class="ref-journal">Curr Opin Immunol. </span>1998;<span class="ref-vol">10</span>:74\xe2\x80\x9381.</span> [<a href="/pubmed/9523115" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Immunol&amp;title=Conserved+motifs+in+T-cell+receptor+CDR1+and+CDR2:+implications+for+ligand+and+CD8+co-receptor+binding.&amp;author=B+Arden&amp;volume=10&amp;publication_year=1998&amp;pages=74-81&amp;pmid=9523115&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Shannon1">14. <span class="element-citation">Shannon CE. A mathematical theory of communication. <span><span class="ref-journal">Bell System Tech J. </span>1948;<span class="ref-vol">27</span>:379-423, 623-656.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bell+System+Tech+J&amp;title=A+mathematical+theory+of+communication.&amp;author=CE+Shannon&amp;volume=27&amp;publication_year=1948&amp;pages=379-656&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Rammensee1">15. <span class="element-citation">Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. <span><span class="ref-journal">Immunogenetics. </span>1999;<span class="ref-vol">50</span>:213\xe2\x80\x93219.</span> [<a href="/pubmed/10602881" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunogenetics&amp;title=SYFPEITHI:+database+for+MHC+ligands+and+peptide+motifs.&amp;author=H+Rammensee&amp;author=J+Bachmann&amp;author=NP+Emmerich&amp;author=OA+Bachor&amp;author=S+Stevanovic&amp;volume=50&amp;publication_year=1999&amp;pages=213-219&amp;pmid=10602881&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Tangri1">16. <span class="element-citation">Tangri S, Ishioka GY, Huang X, Sidney J, Southwood S, et al.  Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide. <span><span class="ref-journal">J Exp Med. </span>2001;<span class="ref-vol">194</span>:833\xe2\x80\x93846.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2195959/">PMC free article</a>]</span> [<a href="/pubmed/11560998" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Structural+features+of+peptide+analogs+of+human+histocompatibility+leukocyte+antigen+class+I+epitopes+that+are+more+potent+and+immunogenic+than+wild-type+peptide.&amp;author=S+Tangri&amp;author=GY+Ishioka&amp;author=X+Huang&amp;author=J+Sidney&amp;author=S+Southwood&amp;volume=194&amp;publication_year=2001&amp;pages=833-846&amp;pmid=11560998&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Welsh1">17. <span class="element-citation">Welsh RM, Selin LK, Szomolanyi-Tsuda E. Immunological memory to viral infections. <span><span class="ref-journal">Annu Rev Immunol. </span>2004;<span class="ref-vol">22</span>:711\xe2\x80\x93743.</span> [<a href="/pubmed/15032594" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Immunol&amp;title=Immunological+memory+to+viral+infections.&amp;author=RM+Welsh&amp;author=LK+Selin&amp;author=E+Szomolanyi-Tsuda&amp;volume=22&amp;publication_year=2004&amp;pages=711-743&amp;pmid=15032594&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Iversen1">18. <span class="element-citation">Iversen AK, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, et al.  Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope. <span><span class="ref-journal">Nat Immunol. </span>2006;<span class="ref-vol">7</span>:179\xe2\x80\x93189.</span> [<a href="/pubmed/16388312" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=Conflicting+selective+forces+affect+T+cell+receptor+contacts+in+an+immunodominant+human+immunodeficiency+virus+epitope.&amp;author=AK+Iversen&amp;author=G+Stewart-Jones&amp;author=GH+Learn&amp;author=N+Christie&amp;author=C+Sylvester-Hviid&amp;volume=7&amp;publication_year=2006&amp;pages=179-189&amp;pmid=16388312&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-LaRosa1">19. <span class="element-citation">La Rosa C, Krishnan R, Markel S, Schneck JP, Houghten R, et al.  Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">97</span>:1776\xe2\x80\x931786.</span> [<a href="/pubmed/11238120" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Enhanced+immune+activity+of+cytotoxic+T-lymphocyte+epitope+analogs+derived+from+positional+scanning+synthetic+combinatorial+libraries.&amp;author=C+La+Rosa&amp;author=R+Krishnan&amp;author=S+Markel&amp;author=JP+Schneck&amp;author=R+Houghten&amp;volume=97&amp;publication_year=2001&amp;pages=1776-1786&amp;pmid=11238120&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Selin1">20. <span class="element-citation">Selin LK, Brehm MA, Naumov YN, Cornberg M, Kim SK, et al.  Memory of mice and men: CD8&#x0002b; T-cell cross-reactivity and heterologous immunity. <span><span class="ref-journal">Immunol Rev. </span>2006;<span class="ref-vol">211</span>:164\xe2\x80\x93181.</span> [<a href="/pubmed/16824126" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Rev&amp;title=Memory+of+mice+and+men:+CD8&#x0002b;+T-cell+cross-reactivity+and+heterologous+immunity.&amp;author=LK+Selin&amp;author=MA+Brehm&amp;author=YN+Naumov&amp;author=M+Cornberg&amp;author=SK+Kim&amp;volume=211&amp;publication_year=2006&amp;pages=164-181&amp;pmid=16824126&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Lauemoller1">21. <span class="element-citation">Lauemoller SL, Kesmir C, Corbet SL, Fomsgaard A, Holm A, et al.  Identifying cytotoxic T cell epitopes from genomic and proteomic information: &#x0201c;The human MHC project.&#x0201d;. <span><span class="ref-journal">Rev Immunogenet. </span>2000;<span class="ref-vol">2</span>:477\xe2\x80\x93491.</span> [<a href="/pubmed/12361091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Rev+Immunogenet&amp;title=Identifying+cytotoxic+T+cell+epitopes+from+genomic+and+proteomic+information:+&#x0201c;The+human+MHC+project.&#x0201d;.&amp;author=SL+Lauemoller&amp;author=C+Kesmir&amp;author=SL+Corbet&amp;author=A+Fomsgaard&amp;author=A+Holm&amp;volume=2&amp;publication_year=2000&amp;pages=477-491&amp;pmid=12361091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Huseby1">22. <span class="element-citation">Huseby ES, White J, Crawford F, Vass T, Becker D, et al.  How the T cell repertoire becomes peptide and MHC specific. <span><span class="ref-journal">Cell. </span>2005;<span class="ref-vol">122</span>:247\xe2\x80\x93260.</span> [<a href="/pubmed/16051149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=How+the+T+cell+repertoire+becomes+peptide+and+MHC+specific.&amp;author=ES+Huseby&amp;author=J+White&amp;author=F+Crawford&amp;author=T+Vass&amp;author=D+Becker&amp;volume=122&amp;publication_year=2005&amp;pages=247-260&amp;pmid=16051149&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Casanova1">23. <span class="element-citation">Casanova JL, Maryanski JL. Antigen-selected T-cell receptor diversity and self-nonself homology. <span><span class="ref-journal">Immunol Today. </span>1993;<span class="ref-vol">14</span>:391\xe2\x80\x93394.</span> [<a href="/pubmed/8397778" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Today&amp;title=Antigen-selected+T-cell+receptor+diversity+and+self-nonself+homology.&amp;author=JL+Casanova&amp;author=JL+Maryanski&amp;volume=14&amp;publication_year=1993&amp;pages=391-394&amp;pmid=8397778&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Rolland1">24. <span class="element-citation">Rolland M, Nickle DC, Deng W, Frahm N, Brander C, et al.  Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins. <span><span class="ref-journal">PLoS ONE. </span>2007;<span class="ref-vol">2</span>:e823.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1952107/">PMC free article</a>]</span> [<a href="/pubmed/17786195" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Recognition+of+HIV-1+peptides+by+host+CTL+is+related+to+HIV-1+similarity+to+human+proteins.&amp;author=M+Rolland&amp;author=DC+Nickle&amp;author=W+Deng&amp;author=N+Frahm&amp;author=C+Brander&amp;volume=2&amp;publication_year=2007&amp;pages=e823&amp;pmid=17786195&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Larsen1">25. <span class="element-citation">Larsen MV, Lundegaard C, Lamberth K, Buus S, Brunak S, et al.  An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. <span><span class="ref-journal">Eur J Immunol. </span>2005;<span class="ref-vol">35</span>:2295\xe2\x80\x932303.</span> [<a href="/pubmed/15997466" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=An+integrative+approach+to+CTL+epitope+prediction:+a+combined+algorithm+integrating+MHC+class+I+binding,+TAP+transport+efficiency,+and+proteasomal+cleavage+predictions.&amp;author=MV+Larsen&amp;author=C+Lundegaard&amp;author=K+Lamberth&amp;author=S+Buus&amp;author=S+Brunak&amp;volume=35&amp;publication_year=2005&amp;pages=2295-2303&amp;pmid=15997466&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Larsen2">26. <span class="element-citation">Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, et al.  Large-Scale validation of methods for cytotoxic T-lymphocyte epitope prediction. <span><span class="ref-journal">BMC Bioinformatics. </span>2007;<span class="ref-vol">8</span>:424.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2194739/">PMC free article</a>]</span> [<a href="/pubmed/17973982" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Bioinformatics&amp;title=Large-Scale+validation+of+methods+for+cytotoxic+T-lymphocyte+epitope+prediction.&amp;author=MV+Larsen&amp;author=C+Lundegaard&amp;author=K+Lamberth&amp;author=S+Buus&amp;author=O+Lund&amp;volume=8&amp;publication_year=2007&amp;pages=424&amp;pmid=17973982&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Brehm1">27. <span class="element-citation">Brehm MA, Pinto AK, Daniels KA, Schneck JP, Welsh RM, et al.  T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. <span><span class="ref-journal">Nat Immunol. </span>2002;<span class="ref-vol">3</span>:627\xe2\x80\x93634.</span> [<a href="/pubmed/12055626" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Immunol&amp;title=T+cell+immunodominance+and+maintenance+of+memory+regulated+by+unexpectedly+cross-reactive+pathogens.&amp;author=MA+Brehm&amp;author=AK+Pinto&amp;author=KA+Daniels&amp;author=JP+Schneck&amp;author=RM+Welsh&amp;volume=3&amp;publication_year=2002&amp;pages=627-634&amp;pmid=12055626&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Kim1">28. <span class="element-citation">Kim SK, Cornberg M, Wang XZ, Chen HD, Selin LK, et al.  Private specificities of CD8 T cell responses control patterns of heterologous immunity. <span><span class="ref-journal">J Exp Med. </span>2005;<span class="ref-vol">201</span>:523\xe2\x80\x93533.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2213046/">PMC free article</a>]</span> [<a href="/pubmed/15710651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Private+specificities+of+CD8+T+cell+responses+control+patterns+of+heterologous+immunity.&amp;author=SK+Kim&amp;author=M+Cornberg&amp;author=XZ+Wang&amp;author=HD+Chen&amp;author=LK+Selin&amp;volume=201&amp;publication_year=2005&amp;pages=523-533&amp;pmid=15710651&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Kulkarni1">29. <span class="element-citation">Kulkarni AB, Morse HC, 3rd, Bennink JR, Yewdell JW, Murphy BR. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8&#x0002b; cytotoxic T cells. <span><span class="ref-journal">J Virol. </span>1993;<span class="ref-vol">67</span>:4086\xe2\x80\x934092.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC237777/">PMC free article</a>]</span> [<a href="/pubmed/7685408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Immunization+of+mice+with+vaccinia+virus-M2+recombinant+induces+epitope-specific+and+cross-reactive+Kd-restricted+CD8&#x0002b;+cytotoxic+T+cells.&amp;author=AB+Kulkarni&amp;author=HC+Morse&amp;author=JR+Bennink&amp;author=JW+Yewdell&amp;author=BR+Murphy&amp;volume=67&amp;publication_year=1993&amp;pages=4086-4092&amp;pmid=7685408&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Wong1">30. <span class="element-citation">Wong CP, Li L, Frelinger JA, Tisch R. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8&#x0002b; T cells in diabetic nonobese diabetic mice. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">176</span>:1637\xe2\x80\x931644.</span> [<a href="/pubmed/16424193" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Early+autoimmune+destruction+of+islet+grafts+is+associated+with+a+restricted+repertoire+of+IGRP-specific+CD8&#x0002b;+T+cells+in+diabetic+nonobese+diabetic+mice.&amp;author=CP+Wong&amp;author=L+Li&amp;author=JA+Frelinger&amp;author=R+Tisch&amp;volume=176&amp;publication_year=2006&amp;pages=1637-1644&amp;pmid=16424193&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Spaulding1">31. <span class="element-citation">Spaulding AC, Kurane I, Ennis FA, Rothman AL. Analysis of murine CD8(&#x0002b;) T-cell clones specific for the Dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. <span><span class="ref-journal">J Virol. </span>1999;<span class="ref-vol">73</span>:398\xe2\x80\x93403.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC103845/">PMC free article</a>]</span> [<a href="/pubmed/9847344" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Analysis+of+murine+CD8(&#x0002b;)+T-cell+clones+specific+for+the+Dengue+virus+NS3+protein:+flavivirus+cross-reactivity+and+influence+of+infecting+serotype.&amp;author=AC+Spaulding&amp;author=I+Kurane&amp;author=FA+Ennis&amp;author=AL+Rothman&amp;volume=73&amp;publication_year=1999&amp;pages=398-403&amp;pmid=9847344&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Clute1">32. <span class="element-citation">Clute SC, Watkin LB, Cornberg M, Naumov YN, Sullivan JL, et al.  Cross-reactive influenza virus-specific CD8&#x0002b; T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. <span><span class="ref-journal">J Clin Invest. </span>2005;<span class="ref-vol">115</span>:3602\xe2\x80\x933612.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1288832/">PMC free article</a>]</span> [<a href="/pubmed/16308574" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Cross-reactive+influenza+virus-specific+CD8&#x0002b;+T+cells+contribute+to+lymphoproliferation+in+Epstein-Barr+virus-associated+infectious+mononucleosis.&amp;author=SC+Clute&amp;author=LB+Watkin&amp;author=M+Cornberg&amp;author=YN+Naumov&amp;author=JL+Sullivan&amp;volume=115&amp;publication_year=2005&amp;pages=3602-3612&amp;pmid=16308574&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Wedemeyer1">33. <span class="element-citation">Wedemeyer H, Mizukoshi E, Davis AR, Bennink JR, Rehermann B. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:11392\xe2\x80\x9311400.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC114725/">PMC free article</a>]</span> [<a href="/pubmed/11689620" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Cross-reactivity+between+hepatitis+C+virus+and+Influenza+A+virus+determinant-specific+cytotoxic+T+cells.&amp;author=H+Wedemeyer&amp;author=E+Mizukoshi&amp;author=AR+Davis&amp;author=JR+Bennink&amp;author=B+Rehermann&amp;volume=75&amp;publication_year=2001&amp;pages=11392-11400&amp;pmid=11689620&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Nilges1">34. <span class="element-citation">Nilges K, Hohn H, Pilch H, Neukirch C, Freitag K, et al.  Human papillomavirus type 16 E7 peptide-directed CD8&#x0002b; T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:5464\xe2\x80\x935474.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC153943/">PMC free article</a>]</span> [<a href="/pubmed/12692247" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+papillomavirus+type+16+E7+peptide-directed+CD8&#x0002b;+T+cells+from+patients+with+cervical+cancer+are+cross-reactive+with+the+coronavirus+NS2+protein.&amp;author=K+Nilges&amp;author=H+Hohn&amp;author=H+Pilch&amp;author=C+Neukirch&amp;author=K+Freitag&amp;volume=77&amp;publication_year=2003&amp;pages=5464-5474&amp;pmid=12692247&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Hohn1">35. <span class="element-citation">Hohn H, Kortsik C, Tully G, Nilges K, Necker A, et al.  Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120. <span><span class="ref-journal">Eur J Immunol. </span>2003;<span class="ref-vol">33</span>:1613\xe2\x80\x931623.</span> [<a href="/pubmed/12778479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=Longitudinal+analysis+of+Mycobacterium+tuberculosis+19-kDa+antigen-specific+T+cells+in+patients+with+pulmonary+tuberculosis:+association+with+disease+activity+and+cross-reactivity+to+a+peptide+from+HIVenv+gp120.&amp;author=H+Hohn&amp;author=C+Kortsik&amp;author=G+Tully&amp;author=K+Nilges&amp;author=A+Necker&amp;volume=33&amp;publication_year=2003&amp;pages=1613-1623&amp;pmid=12778479&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Zivny1">36. <span class="element-citation">Zivny J, DeFronzo M, Jarry W, Jameson J, Cruz J, et al.  Partial agonist effect influences the CTL response to a heterologous dengue virus serotype. <span><span class="ref-journal">J Immunol. </span>1999;<span class="ref-vol">163</span>:2754\xe2\x80\x932760.</span> [<a href="/pubmed/10453018" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Partial+agonist+effect+influences+the+CTL+response+to+a+heterologous+dengue+virus+serotype.&amp;author=J+Zivny&amp;author=M+DeFronzo&amp;author=W+Jarry&amp;author=J+Jameson&amp;author=J+Cruz&amp;volume=163&amp;publication_year=1999&amp;pages=2754-2760&amp;pmid=10453018&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-VanEpps1">37. <span class="element-citation">Van Epps HL, Schmaljohn CS, Ennis FA. Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(&#x0002b;) CTL epitopes on nucleocapsid protein. <span><span class="ref-journal">J Virol. </span>1999;<span class="ref-vol">73</span>:5301\xe2\x80\x935308.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC112585/">PMC free article</a>]</span> [<a href="/pubmed/10364276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+memory+cytotoxic+T-lymphocyte+(CTL)+responses+to+Hantaan+virus+infection:+identification+of+virus-specific+and+cross-reactive+CD8(&#x0002b;)+CTL+epitopes+on+nucleocapsid+protein.&amp;author=HL+Van+Epps&amp;author=CS+Schmaljohn&amp;author=FA+Ennis&amp;volume=73&amp;publication_year=1999&amp;pages=5301-5308&amp;pmid=10364276&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0001831-Lund1">38. <span class="element-citation">Lund O, Nielsen M, Kesmir C, Petersen AG, Lundegaard C, et al.  Definition of supertypes for HLA molecules using clustering of specificity matrices. <span><span class="ref-journal">Immunogenetics. </span>2004;<span class="ref-vol">55</span>:797\xe2\x80\x93810.</span> [<a href="/pubmed/14963618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunogenetics&amp;title=Definition+of+supertypes+for+HLA+molecules+using+clustering+of+specificity+matrices.&amp;author=O+Lund&amp;author=M+Nielsen&amp;author=C+Kesmir&amp;author=AG+Petersen&amp;author=C+Lundegaard&amp;volume=55&amp;publication_year=2004&amp;pages=797-810&amp;pmid=14963618&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2263130&amp;issue-id=161333&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2263130/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2263130/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2263130/pdf/pone.0001831.pdf">PDF (255K)</a></li> | <li><a href="#" data-citationid="PMC2263130" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2263130%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2263130%2F&amp;text=Amino%20Acid%20Similarity%20Accounts%20for%20T%20Cell%20Cross-Reactivity%20and%20for%20%E2%80%9CHoles%E2%80%9D%20in%20the%20T%20Cell%20Repertoire"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2263130%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18350167" data-aiid="2263130" data-aid="2263130" data-iid="161333" data-domainid="440" data-domain="plosone" data-accid="PMC2263130" data-md5="a0e1784d2a983184bd24f1776a4f1372"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:38:36-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A47C9E99B04610000000000BE00BE&amp;ncbi_session=8A1A47C9E99B15B1_0190SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2263130%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2263130/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A47C9E99B15B1_0190SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'